Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Haryana: KARNAL to get...

    Haryana: KARNAL to get Mega pharma park, says govt

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-17T15:10:47+05:30  |  Updated On 17 Oct 2018 3:10 PM IST
    Haryana: KARNAL to get Mega pharma park, says govt

    Chandigarh: The Haryana government Tuesday said a pharma park will be established over 100 acres of land in Karnal.




    Also, the state's Industries and Commerce Minister Vipul Goel said that Haryana Pharmaceutical Policy 2018 is being framed to facilitate pharmaceutical companies in the state. The minister was speaking at an event 'Stakeholder Consultation for Formulation of Pharma Policy, Haryana', here on Tuesday.

    Representatives of various pharmaceutical companies of Haryana, Chandigarh, Uttar Pradesh, Himachal Pradesh, Uttarakhand and other states attended the meeting organized by the Haryana Industries and Commerce Department, a state government release said.

    Urging all stakeholders to invest in the pharmaceutical sector in Haryana, Goel said the pharma park would be established over 100 acres.

    He said special concessions and rebates would be given to those setting up their companies in the pharmaceutical sector in Haryana.

    Investment of about Rs 3,000 crore is expected to be made in this pharma park which would provide employment to about 33,000 persons, he said.

    Goel said the aim of the state government to frame Haryana Pharmaceutical Policy 2018 is to simplify the working of pharma companies and provide maximum employment to youth in the state.

    He said that Haryana is a leading state in terms of ensuring industrial development, developing industrial eco-system and providing facilities to investors.

    The Minister said that in 2015, when the Government of India had launched ranking for ease of doing business, Haryana was at 14th position.

    "As a result of the measures taken by the present state government, now the State has reached at the third position in terms of Ease of Doing Business, and a target has been set to reach the top in a short period," he added.

    ChandigarhCommerce DepartmentgovernmentHaryanaHaryana Pharmaceutical PolicyHimachal PradeshKarnalMega pharma parkpharma parkpharma park haryanapharma park karnalpharmaceutical companiesStakeholder Consultation for Formulation of Pharma PolicyUttar PradeshUttarakhandVipul Goel

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok